Many research studies show, pain is a significant source of suffering for many people and seriously affects their quality of life. Treatment of these patients is a great challenge and requires special approaches.
We are proud to present the return of 16th Annual
Pain Therapeutics to London, UK on 23-24 of May 2016. Through a series of interactive presentations and panel discussions, the event will introduce the insights from key industry leaders, outlining the current activities, key issues and trends in pain medicine. This event will bring highlights of research and development in the pain relief field as well as new models and innovation of overcoming issues in the niche market.
Benefits of Attending
- Presentations on strategies to minimise risk for opioid dependence
- Discover Pfizer's achievements for the past year on voltage gated sodium channels
- Learn about Glenmark's experience on pain drug discovery
- Join the debate in interactive panel discussion on medical incidents in experimental drug trials
- Hear presentations on cutting edge clinical developments from industry leaders and scientific pioneers
Plus 2 Interactive Half-Day Post Conference Workshops | 25th May 2016
Animal models for the study of compounds in pain therapy: From screening to translational modelsHosted by: Dr Sigal Meilin, Chief Scientific Officer, MD Biosciences, Innovalora Ltd
8:30 - 12:30
Pain is a disease, not a symptom
Workshop Leader: Karin Hygge Blakeman, Medical Scientific Liason, Grunenthal
13:30-17:30
Speakers
- Achim Kless, Associate Scientific Director , Grunenthal Gmbh
- Andrea Houghton, Executive Director, MSD, USA
- Aoibhinn McDonnell, Clinician, Director, Pfizer
- Catherine Stehman-Breen, VP Clinical Sciences, Regeneron Pharmaceuitcals Inc
- Chao Chen, Therapy Area Head, Glaxosmithkline
- Darren Cawkill, Head of Assay Development & Screening, Pfizer
- Fiona Boissonade, Head of Neuroscience Research Group, The University Of Sheffield
- Geert Jan Groeneveld, Research Director Neurology & Pain, Centre for Human Drug Research
- Marten Harbers, Project Manager, PRA Health Sciences
- Martin Koltzenburg, Chair of Clinical Neurophysiology, University College London
- Neelima Khairatkar Joshi, Sr Vice President, Glenmark Pharmaceuticals
- Ozgur Sancak, Global Medical Science Lead for Pain, Reckitt Benckiser
- Praveen Anand, Professor of Neurology, Imperial College London
- Remigiusz Lecybyl, Consultant in Chronic Pain, The Lewisham Hospital N H S Trust
- Shaloo Pandhi, Global Program Medical Director, Novartis
- Sigal Meilin, Scientific Director, MD Biosciences
- Stephen Doberstein, Senior Vice President and Chief Scientific Officer, Nektar Therapeutics
- Steven Kamerling, Therapeutic Area Head for Pain, Inflammation and Oncology, Zoetis
- Thomas Christoph, Senior Director, Head of Pain Pharmacology, Grunenthal GmbH
Please fill in your name and email to receive the conference agenda of this event.
The agenda is available as PDF under downloads at the right side of the page.
Venue
Holiday Inn Kensington Forum
97 Cromwell Rd, Kensington, SW7 4DN
London, UK
Venue
Holiday Inn Kensington Forum97 Cromwell Road
London
United Kingdom
